Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe page’s site release/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedPadova, Italy, 35128 was added to the locations list and Padua, Italy, 35128 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedLocation name updated from Napoli, Italy, 80100 to Naples, Italy, 80100; page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedPage revision updated to v3.4.2 (replacing v3.4.1); this minor behind-the-scenes change does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.